Maple, Canada

Fabrizio Mastronardi



Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Maple, CA (2016 - 2020)
  • Ontario, CA (2016 - 2022)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Fabrizio Mastronardi: Innovator in Pharmaceutical Compositions

Introduction

Fabrizio Mastronardi is a notable inventor based in Maple, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating inflammatory and neurodegenerative diseases. With a total of 7 patents to his name, Mastronardi's work is paving the way for advancements in medical treatments.

Latest Patents

Mastronardi's latest patents focus on pharmaceutical compositions that comprise one or more pyrone compounds. These compositions are designed for treating, preventing, or ameliorating symptoms associated with inflammatory, neurodegenerative, or immune-mediated diseases, such as multiple sclerosis. The innovative formulations include a pyrone compound and a pharmaceutically acceptable excipient, showcasing his commitment to addressing complex health issues.

Career Highlights

Throughout his career, Mastronardi has worked with various companies, including Biotheryx, Inc. and Adiptotec, Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Mastronardi has collaborated with notable professionals in his field, including Armen Manoukian and Sam Scanga. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

Fabrizio Mastronardi's contributions to pharmaceutical innovations demonstrate his dedication to improving healthcare through scientific research. His work continues to influence the treatment of serious medical conditions, making him a significant figure in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…